Neximmune Inc. (NEXI) NASDAQ
$5.61 0.10 (1.81%)
Market Cap: $76.33M
As of 03/28/24 04:00 PM EDT. Market closed.
Neximmune Inc. (NEXI)
NASDAQ
$5.61
0.10 (1.81%)
Market Cap: $76.33M
As of 03/28/24 04:00 PM EDT. Market closed.
neximmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary aim™ technology. this nanotechnology platform, originally developed at johns hopkins university, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted t cell response against a disease. ... read more
neximmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary aim™ technology. this nanotechnology platform, originally developed at johns hopkins university, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted t cell response against a disease. central to the aim technology are artificial antigen presenting cells (aapc) that present antigens to t cells eliciting a highly targeted therapy driven by the patient’s immune system. these aapc can be rapidly engineered to elicit a specific immune attack that can be directed toward any foreign substance or cell type in a patient’s body. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
BARER SOL J | Director | Mar 30, 2023 | Buy | $0.41 | 400,000 | 164,120 | 2,217,814 | Mar 31, 2023, 04:56 PM |
BARER SOL J | Director | Nov 17, 2022 | Buy | $0.48 | 75,000 | 35,917 | 1,817,814 | Nov 17, 2022, 08:40 PM |
BARER SOL J | Director | Nov 16, 2022 | Buy | $0.48 | 125,000 | 60,300 | 1,742,814 | Nov 17, 2022, 08:40 PM |
Verstandig Grant | Director | Jun 03, 2022 | Buy | $2.22 | 15,000 | 33,374 | 1,053,619 | Jun 07, 2022, 06:17 PM |
Verstandig Grant | Director | Jun 06, 2022 | Buy | $2.14 | 25,000 | 53,537 | 1,078,619 | Jun 07, 2022, 06:17 PM |
Verstandig Grant | Director | Jun 07, 2022 | Buy | $2.28 | 26,876 | 61,385 | 1,105,495 | Jun 07, 2022, 06:17 PM |
Verstandig Grant | Director | May 31, 2022 | Buy | $2.11 | 45,024 | 95,118 | 950,519 | Jun 02, 2022, 07:42 PM |
Verstandig Grant | Director | Jun 01, 2022 | Buy | $2.38 | 40,200 | 95,760 | 990,719 | Jun 02, 2022, 07:42 PM |
Verstandig Grant | Director | Jun 02, 2022 | Buy | $2.23 | 47,900 | 106,683 | 1,038,619 | Jun 02, 2022, 07:42 PM |
BARER SOL J | Director | May 31, 2022 | Buy | $2.19 | 39,280 | 85,894 | 1,557,094 | Jun 02, 2022, 07:41 PM |
BARER SOL J | Director | Jun 01, 2022 | Buy | $2.35 | 40,000 | 94,160 | 1,597,094 | Jun 02, 2022, 07:41 PM |
BARER SOL J | Director | Jun 02, 2022 | Buy | $2.22 | 20,720 | 46,100 | 1,617,814 | Jun 02, 2022, 07:41 PM |
Jones Kristi | President and CEO | Mar 29, 2022 | Buy | $3.74 | 10,000 | 37,400 | 73,078 | Mar 30, 2022, 07:57 PM |
Verstandig Grant | Director | Mar 24, 2022 | Buy | $3.35 | 39,995 | 133,983 | 754,890 | Mar 28, 2022, 04:15 PM |
Verstandig Grant | Director | Mar 28, 2022 | Buy | $3.76 | 18,983 | 71,376 | 905,495 | Mar 28, 2022, 04:15 PM |
Verstandig Grant | Director | Mar 25, 2022 | Buy | $4.14 | 131,622 | 544,915 | 886,512 | Mar 28, 2022, 04:15 PM |
BARER SOL J | Director | Mar 23, 2022 | Buy | $2.67 | 10,000 | 26,653 | 1,517,814 | Mar 24, 2022, 04:15 PM |
BARER SOL J | Director | Mar 22, 2022 | Buy | $2.41 | 30,000 | 72,300 | 1,507,814 | Mar 23, 2022, 04:15 PM |
BARER SOL J | Director | Mar 21, 2022 | Buy | $2.14 | 30,000 | 64,080 | 1,477,814 | Mar 22, 2022, 04:15 PM |
BARER SOL J | Director | Mar 18, 2022 | Buy | $2.11 | 30,000 | 63,210 | 1,447,814 | Mar 21, 2022, 04:10 PM |
Roemer Alan S. | Director | Dec 21, 2021 | Option Exercise | $3.63 | 67,657 | 245,867 | 195,641 | Dec 22, 2021, 05:00 PM |
BARER SOL J | Director | Dec 21, 2021 | Option Exercise | $5.17 | 50,000 | 258,500 | 1,417,814 | Dec 22, 2021, 08:00 AM |
Trainer John | Chief Financial Officer | Jul 08, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 61,770 | Jul 09, 2021, 04:19 PM |
Trainer John | Chief Financial Officer | May 08, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 54,906 | May 19, 2021, 04:16 PM |
Trainer John | Chief Financial Officer | Apr 08, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 51,474 | May 19, 2021, 04:16 PM |
Trainer John | Chief Financial Officer | Mar 10, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 48,042 | Mar 12, 2021, 02:00 PM |
Jones Kristi | Chief Operating Officer | Feb 17, 2021 | Buy | $17.00 | 911 | 15,487 | 63,078 | Feb 19, 2021, 04:30 PM |
ZELDIS JEROME B | Executive VP of Research & Dev | Feb 17, 2021 | Buy | $17.00 | 5,882 | 99,994 | 5,882 | Feb 19, 2021, 04:30 PM |
Verstandig Grant | Director | Feb 17, 2021 | Buy | $17.00 | 175,000 | 2,975,000 | 714,895 | Feb 19, 2021, 04:25 PM |
BARER SOL J | Director | Feb 17, 2021 | Buy | $17.00 | 60,000 | 1,020,000 | 1,538,013 | Feb 19, 2021, 04:20 PM |
Owner | Relationship | Date | Value($) |
BARER SOL J | Director | 03/30/2023 | 164,120 |
BARER SOL J | Director | 11/17/2022 | 35,917 |
BARER SOL J | Director | 11/16/2022 | 60,300 |
Verstandig Grant | Director | 06/03/2022 | 33,374 |
Verstandig Grant | Director | 06/06/2022 | 53,537 |
Verstandig Grant | Director | 06/07/2022 | 61,385 |
Verstandig Grant | Director | 05/31/2022 | 95,118 |
Verstandig Grant | Director | 06/01/2022 | 95,760 |
Verstandig Grant | Director | 06/02/2022 | 106,683 |
BARER SOL J | Director | 05/31/2022 | 85,894 |
BARER SOL J | Director | 06/01/2022 | 94,160 |
BARER SOL J | Director | 06/02/2022 | 46,100 |
Jones Kristi | President and CEO | 03/29/2022 | 37,400 |
Verstandig Grant | Director | 03/24/2022 | 133,983 |
Verstandig Grant | Director | 03/28/2022 | 71,376 |
Verstandig Grant | Director | 03/25/2022 | 544,915 |
BARER SOL J | Director | 03/23/2022 | 26,653 |
BARER SOL J | Director | 03/22/2022 | 72,300 |
BARER SOL J | Director | 03/21/2022 | 64,080 |
BARER SOL J | Director | 03/18/2022 | 63,210 |
Roemer Alan S. | Director | 12/21/2021 | 245,867 |
BARER SOL J | Director | 12/21/2021 | 258,500 |
Trainer John | Chief Financial Officer | 07/08/2021 | 17,743 |
Trainer John | Chief Financial Officer | 05/08/2021 | 17,743 |
Trainer John | Chief Financial Officer | 04/08/2021 | 17,743 |
Trainer John | Chief Financial Officer | 03/10/2021 | 17,743 |
Jones Kristi | Chief Operating Officer | 02/17/2021 | 15,487 |
ZELDIS JEROME B | Executive VP of Research & Dev | 02/17/2021 | 99,994 |
Verstandig Grant | Director | 02/17/2021 | 2,975,000 |
BARER SOL J | Director | 02/17/2021 | 1,020,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 801,371 | 0.00038% | Exited | Other |
GEODE CAPITAL MANAGEMENT, LLC | 108,143 | 0% | Exited | Other |
RENAISSANCE TECHNOLOGIES LLC | 65,500 | 0.00002% | Exited | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 32,054 | 0.00015% | New | Other |
BLACKROCK INC. | 360 | 0% | Exited | Other |
BLACKROCK INC. | 14 | 0% | New | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View